Safety and efficacy of Limosilactobacillus reuteri DSM 32264 as a cat feed additive

The additive consisting of L. reuteri DSM 32264 has the potential to improve fecal consistency by reducing the moisture content of the feces of cats receiving it.

Published on
, byGiulia Pignataro

As anticipated in thearticle published on the dog also with regard to the cat, a scientific opinion on the efficacy of a product consisting of Limosilactobacillus reuteri(formerly Lactobacillus reuteri) DSM 32264 as a zootechnical additive for cats was published in 2022 by Efsa.

Regulation (EC) No. 1831/2003 sets out the rules governing the Community authorization of additives for use in animal nutrition, and in particular, Article 9 defines the terms of authorization by the committee formed by a panel of scientific experts on additives and products or substances used in animal feed of the European Food Safety Authority (“EFSA”).

Applicant NBF Lanes s.r.l. is seeking community authorization of Lactobacillus reuteri DSM 32264 as a feed additive for use as a stabilizer of intestinal flora in cats.

The studies were conducted on adult cats of both sexes and of different breeds (Chartreux, Persian, and Scottish Fold) and body weights (BW) fed a once-daily extruded dry commercial food based on their maintenance energy requirements. The cats were visited daily by a veterinarian.

Before the start of the study, cats were acclimatized in individual housing for 14 days during which they received unsupplemented feed. At the beginning of the study, cats were randomly assigned to the two dietary treatments: control and L. reuteri DSM 32264 at 1 x1010 CFU/kg feed.

Body weight and body condition score (BCS) were recorded at days 0, 7, 14, 21, 28 and 35. On the same days, stool samples were collected and moisture content (FM) and consistency (FS, faecal score) were evaluated. In addition, microbiological analyses were carried out (enumeration of lactobacilli and Escherichia coli or coliform) on samples collected at days 0, 7, 21 and 35.

The additive consisting of L. reuteri DSM 32264 has the potential to improve fecal consistency by reducing the moisture content of the feces of cats receiving it. Regarding fecal microbiological analysis, in all studies at the end of the experimental period, lactobacillus counts were higher and E. coli counts were lower in samples from animals receiving the additive than in those from control animals.

Reference

EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fasmon Durjava M, Kouba M, Lopez-Alonso M, Lopez Puente S, Marcon F, Mayo B, Pechova A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Martelli G, Anguita M, Galobart J, Ortuno J, Revez J and Brozzi R, 2022. ~ Scientific Opinion on the safety and efficacy of a feed additive consisting of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) DSM 32264 as a feed additive for cats (NBF Lanes s.r.l.). EFSA Journal 2022;20(8):7437, 7 pp. https://doi.org/10.2903/j.efsa.2022.7437

Explore the latest content
06_02_2024_Probiotici per cani e gatti a che punto siamo
Probiotics for dogs and cats: where do we stand?
02_02_2024_Enteropatia cronica nei cani effetti di simbiotico e IgY sul microbiota intestinale
Chronic enteropathy in dogs: effects of symbiotic and IgY on gut microbiota
11_01_2024_Caratteristiche probiotiche del Lactobacillus reuteri
Probiotic characteristics of Lactobacillus reuteri
See more content on
06_02_2024_Probiotici per cani e gatti a che punto siamo
Probiotics for dogs and cats: where do we stand?
02_02_2024_Enteropatia cronica nei cani effetti di simbiotico e IgY sul microbiota intestinale
Chronic enteropathy in dogs: effects of symbiotic and IgY on gut microbiota
19_01_2024_Sicurezza ed efficacia di Limosilactobacillus reuteri DSM 32264 come additivo per mangimi per gatti
Safety and efficacy of Limosilactobacillus reuteri DSM 32264 as a cat feed additive
11_01_2024_Caratteristiche probiotiche del Lactobacillus reuteri
Probiotic characteristics of Lactobacillus reuteri
11_01_2024_Rapporto ufficiale EFSA sull’efficacia di Lactobacillus reuteri DSM 32203 (NBF LANES) per cani
Official EFSA report on the efficacy of Lactobacillus reuteri DSM 32203 (NBF LANES) for dogs
11_01_2024_Effetti del Lactobacillus reuteri NBF1 sulla salute del cane sano
Effects of Lactobacillus reuteri NBF1 on the health of the healthy dog
11_01_2024_Effetti dell'integrazione di Lactobacillus reuteri NBF 1 sul Bouledogue francese
Effects of Lactobacillus reuteri NBF 1 supplementation on French Bouledogue
21_07_2023_Cani obesi e cani normopeso ecco come cambia il microbiota
Obese dogs and normal-weight dogs: here's how the microbiota changes